Irina Barash
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0002-0358-6591Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 5 papers. Top paper: “Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial”.
Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash, Marc P. Bonaca, Maria Borentain +94 more
Chenglin Zhu, Irina Barash, Jon D. Blumenfeld, Xinzi He, Arindam RoyChoudhury +3 more
Jon D. Blumenfeld, Sadjad Riyahi, Xianfu Luo, Hanna Rennert, Irina Barash +2 more
Christopher M. O’Connor, Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash +84 more
Stefania Lando, Shunsuke Murata, Morgan E. Grams, Edouard L. Fu, Frida Welander +8 more